History
JW Euvipharm Joint Stock Company is preparing for a leap forward
as a leading pharmaceutical company in Vietnam’s domestic market.
2023
Acquired Euvipharm Joint Stock Company from JW Pharmaceutical
2022
MFDS Inspection
2020
GSP license acquisition
2019
Acquired Euvipharm Joint Stock Company from JW Pharmaceutical
